Subgroup analysis showed that IL–10 overexpression was associated with worse 5-year OS in hematological malignancies (OR = 3.59, 95% CI = 2.26 to 5.72, P < 0.0001), however the amount of 5-year OS data in solid tumors was not enough for meta-analysis. Here, IL10 is linked to hematologic disorder.